- Home
- TXMD vs SBEV Comparison
TXMD vs SBEV Comparison
Compare TXMD & SBEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- SBEV
- Stock Information
- Founded
- TXMD 2008
- SBEV 1992
- Country
- TXMD United States
- SBEV United States
- Employees
- TXMD N/A
- SBEV 32
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- SBEV Beverages (Production/Distribution)
- Sector
- TXMD Health Care
- SBEV Consumer Staples
- Exchange
- TXMD Nasdaq
- SBEV Nasdaq
- Market Cap
- TXMD 12.8M
- SBEV 10.3M
- IPO Year
- TXMD N/A
- SBEV N/A
- Fundamental
- Price
- TXMD $1.30
- SBEV $0.17
- Analyst Decision
- TXMD
- SBEV Strong Buy
- Analyst Count
- TXMD 0
- SBEV 2
- Target Price
- TXMD N/A
- SBEV $0.75
- AVG Volume (30 Days)
- TXMD 738.0K
- SBEV 2.5M
- Earning Date
- TXMD 03-28-2025
- SBEV 03-28-2025
- Dividend Yield
- TXMD N/A
- SBEV N/A
- EPS Growth
- TXMD N/A
- SBEV N/A
- EPS
- TXMD N/A
- SBEV N/A
- Revenue
- TXMD $1,596,000.00
- SBEV $6,257,725.00
- Revenue This Year
- TXMD $605.07
- SBEV N/A
- Revenue Next Year
- TXMD $1.11
- SBEV $151.31
- P/E Ratio
- TXMD N/A
- SBEV N/A
- Revenue Growth
- TXMD N/A
- SBEV N/A
- 52 Week Low
- TXMD $0.70
- SBEV $0.14
- 52 Week High
- TXMD $2.75
- SBEV $0.73
- Technical
- Relative Strength Index (RSI)
- TXMD 68.51
- SBEV 40.69
- Support Level
- TXMD $0.95
- SBEV $0.16
- Resistance Level
- TXMD $1.08
- SBEV $0.18
- Average True Range (ATR)
- TXMD 0.09
- SBEV 0.02
- MACD
- TXMD 0.02
- SBEV -0.00
- Stochastic Oscillator
- TXMD 49.30
- SBEV 17.86
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About SBEV Splash Beverage Group Inc. (NV)
Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce segment. Qplash is a wholly owned division of Splash. It is the company's first entry point into the e-commerce channel. For beverage-alcohol products, the company operate within what is referred to as a "Three Tier Distribution System" where manufacturers are not permitted to sell directly to retailers, but instead, contract for local and regional distribution with independent distributors.